Horizon Therapeutics Public Ltd Co

Man Group plc

Report date

9/30/2023

Quarter

2023 Q3

Filed

11/14/2023

Shares

932,535

Value ($000)

107,885

Weight

0.3%

2019 Q4 - 2023 Q3 (16 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	11/14/2023	107,885	0.3%	932,535	9/30/2023
2023 Q2	8/14/2023	105,478	0.3%	1,025,550	6/30/2023
2023 Q1	5/15/2023	88,663	0.3%	812,381	3/31/2023
2022 Q4	2/14/2023	74,087	0.3%	651,030	12/31/2022
2022 Q3	11/14/2022	22,769	0.1%	367,891	9/30/2022
2022 Q2	8/15/2022	8,503	0.0%	106,606	6/30/2022
2022 Q1	5/16/2022	990	0.0%	9,409	3/31/2022
2021 Q4	2/14/2022	5,365	0.0%	49,783	12/31/2021
2021 Q3	11/15/2021	905	0.0%	8,256	9/30/2021
2021 Q2	8/16/2021	2,872	0.0%	30,667	6/30/2021
2021 Q1	5/17/2021	3,226	0.0%	35,055	3/31/2021
2020 Q4	2/16/2021	2,478	0.0%	33,867	12/31/2020
2020 Q3	11/16/2020	5,128	0.0%	66,017	9/30/2020
2020 Q2	8/14/2020	430	0.0%	7,736	6/30/2020
2020 Q1	5/15/2020	3,682	0.0%	124,334	3/31/2020
2019 Q4	2/18/2020	9,388	0.0%	259,337	12/31/2019